CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 62 filers reported holding CORVUS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,607 | +60.7% | 1,101 | +175.2% | 0.00% | – |
Q1 2020 | $1,000 | -99.9% | 400 | -99.9% | 0.00% | – |
Q3 2019 | $1,284,000 | -40.6% | 426,656 | -26.2% | 0.00% | – |
Q2 2019 | $2,161,000 | -36.4% | 577,856 | -31.7% | 0.00% | – |
Q1 2019 | $3,399,000 | -11.0% | 845,556 | -18.8% | 0.00% | -100.0% |
Q4 2018 | $3,821,000 | -77.9% | 1,041,256 | -48.4% | 0.00% | -50.0% |
Q3 2018 | $17,321,000 | -36.3% | 2,018,812 | -18.5% | 0.00% | -33.3% |
Q2 2018 | $27,212,000 | -7.5% | 2,478,297 | -2.9% | 0.00% | 0.0% |
Q1 2018 | $29,426,000 | +122.7% | 2,552,120 | +100.1% | 0.00% | +50.0% |
Q4 2017 | $13,216,000 | -3.0% | 1,275,650 | +49.3% | 0.00% | 0.0% |
Q3 2017 | $13,621,000 | +7.2% | 854,511 | -18.7% | 0.00% | 0.0% |
Q2 2017 | $12,712,000 | -71.2% | 1,050,611 | -50.5% | 0.00% | -66.7% |
Q1 2017 | $44,097,000 | +33.9% | 2,123,106 | -7.8% | 0.01% | +50.0% |
Q4 2016 | $32,926,000 | +94.4% | 2,302,497 | +123.6% | 0.00% | +100.0% |
Q3 2016 | $16,940,000 | -48.6% | 1,029,800 | -55.4% | 0.00% | -50.0% |
Q2 2016 | $32,959,000 | +3.6% | 2,311,297 | +5.3% | 0.00% | 0.0% |
Q1 2016 | $31,824,000 | – | 2,194,797 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ADAMS STREET PARTNERS LLC | 3,275,616 | $2,784,274 | 0.93% |
CHI Advisors LLC | 2,384,402 | $2,026,742 | 0.54% |
Telemetry Investments, L.L.C. | 390,000 | $332 | 0.52% |
Orbimed Advisors | 6,943,654 | $5,902,106 | 0.11% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 548,727 | $466,418 | 0.07% |
BVF INC/IL | 1,370,947 | $1,165,305 | 0.05% |
JACKSON SQUARE CAPITAL, LLC | 63,773 | $54,207 | 0.03% |
Artal Group S.A. | 500,000 | $425 | 0.02% |
Hikari Power Ltd | 49,959 | $42 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 159,300 | $135,405 | 0.00% |